Table 2.
BMI n (%) |
P value | ||
---|---|---|---|
Normal BMI n=36 | High BMI (Obese) n=44 | ||
Menopausal Status | |||
Premenopausal =16pt. | 13 (36.1) | 3 (6.8) | 0.001 |
Postmenopausal =64pt. | 23 (63.9) | 41 (93.2) | |
Histopathology | |||
IDC =75 pt | 36 (100.0) | 39 (88.6) | 0.037 |
ILC =5 pt | 0 (0.00) | 5 (11.4) | |
Disease stage n (%) | |||
I = 21 pt | 12 (33.3) | 9 (20.5) | |
II = 26 pt | 11 (30.6) | 15 (34.1) | 0.5 |
IIIA = 33 pt | 13 (36.1) | 20 (45.4) | |
ER status | |||
Positive =67 pt | 26 (72.2) | 41 (93.2) | 0.011 |
Negative =13pt | 10 (27.8) | 3 (6.8) | |
PR status | |||
Positive = 51 pt | 24 (66.7) | 27 (61.4) | 0.62 |
Negative = 29 pt | 12 (33.3) | 17 (38.6) | |
HER2 | |||
Positive = 17 pt | 4 (11.1) | 13 (29.5) | 0.045 |
Negative = 63 pt | 32 (88.9) | 31 (70.5) | |
Tumor grade n (%) | |||
Low = 5 pt | 3 (8.3) | 2 (45.5) | 0.76 |
Intermediate = 49 pt | 21 (58.3) | 28 (36.7) | |
High = 26 pt | 12 (33.3) | 14 (31.8) | |
LVI n (%) | 10 (27.8) | 16 (36.4) | 0.42 |
Ki-67 (%) median (IQR) | 15.0 (5.0 – 45.0) | 35 (7.5 – 75.0) | 0.11 |
Disease status/Treatment outcome | |||
Relapse n (%) | 4 (11.1) | 10 (22.7) | 0.16 |
Relapse time (months) | 14.5 | 12.0 | 0.17 |
Median (IQR) | (11.0 – 15.8) | (11.0 - 13.0) | |
Survival time (months) | 35.0 | 35.5 | 0.15 |
Median (IQR) | (31.0 – 37.0) | (34.0-36.0) | |
Mortality n (%) | 1 (2.3) | 6 (16.7) | 0.023 |